Compare JPMorgan Ultra Short Income ETF (JPST) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Ultra Short Income ETF vs Marsh & McLennan Companies, Inc. — how do they compare? JPMorgan Ultra Short Income ETF trades at $50.5, while Marsh & McLennan Companies, Inc. trades at $180.04 (market cap $87.77B). The key difference: Marsh & McLennan Companies, Inc. pays a 2.17% dividend while JPMorgan Ultra Short Income ETF pays none, and Marsh & McLennan Companies, Inc. is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| JPST | MRSH | |
|---|---|---|
Sector | Leveraged / Inverse | Financials |
52-Week High | $50.78 | $211.21 |
52-Week Low | $50.40 | $157.32 |
Market Cap | — | $87.77B |
Enterprise Value | — | $108.61B |
Dividend Yield | — | 2.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPST (JPMorgan Ultra-Short Income ETF) trades at $50.49, showing minimal daily movement with a slight decline of $0.01 (-0.02%). The ETF maintains a bullish technical signal overall, supported by moving averages, while oscillators remain neutral. Recent institutional activity includes Alpha Zero LLC's $2.30 million investment and Greenwood Gearhart LLC increasing its holdings to $88.04 million, indicating strong institutional confidence. The fund focuses on high-quality, short-term bonds with low duration risk, positioning it as a cash alternative for risk-averse investors.
The outlook for JPST remains stable, benefiting from its ultra-short income strategy amid potential Fed rate stability. Investment opportunities include capital preservation and steady income via dividends, with recent payouts of $0.17-$0.18. Risks involve interest rate sensitivity and inflationary pressures, though the ETF's low duration mitigates volatility. Institutional accumulation and positive media coverage support a cautious bullish stance for income-focused portfolios.
Marsh (MRSH) trades at $181.59, down 0.32% on the day, with a bullish technical signal from moving averages and support at $180. The company reported strong Q2 2026 earnings, beating estimates with $2.96 EPS versus $2.88 expected, driven by 6% revenue growth to $7.4 billion. Fundamentals show robust profitability with a 14.26% net margin and 27.42% ROE, while valuation ratios like P/E of 22.77 and P/S of 3.26 reflect premium pricing. Recent news highlights a 10% dividend increase to $0.99 per share, payable in August 2026.
The outlook for MRSH is positive, supported by consistent earnings beats and strategic AI investments, but risks include rising operating expenses and softer insurance pricing. Analysts maintain a consensus price target of $203.75, implying 12% upside, with 11 buy ratings outweighing 1 sell. Investors should monitor expense management and organic growth sustainability amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
